Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

The global market for reusable insulin pen has been growing with a mature market. The growth is mostly with a rising population of diabetic patients. U.S., India, China, and Brazil are some emerging countries for the growth of insulin.

Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India, and Brazil by the year-end of 2022.
 
 Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices.
 
 China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. The United States is expected to become the third largest reusable insulin pen market by 2022.
 
 The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in-depth analysis of the overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India, and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market.
 
 The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook, and the latest development and trends of the insulin pen market.
 
 All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints
 
 1. Overall Diabetes Population (2011 – 2022)
 2. Insulin Users (2011 – 2022)
 3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
 4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
 
 
 Ten Major Markets(10MM) Covered in the Report are as follows:
 
 1. United States
 2. United Kingdom
 3. France
 4. Italy
 5. Spain
 6. Germany
 7. Japan
 8. China
 9. India
 10. Brazil
 
 Key Companies Covered in the Report are as follows:
 
 1. Novo Nordisk
 2. Eli Lilly
 3. Sanofi
 4. Owen Mumford
 5. Ypsomed
 6. Biocon Ltd.

 1. Executive Summary
 
 2. Reusable (Cartridge) Insulin Pen Market Environment & Trend (2011 – 2022)
 2.1 Reusable (Cartridge) Insulin Pen Users
 2.2 Reusable (Cartridge) Insulin Pen Market
 
 3. Reusable (Cartridge) Insulin Pen Market Share Analysis (2011 - 2022)
 3.1 Reusable (Cartridge) Insulin Pen Users Share
 3.2 Reusable (Cartridge) Insulin Pen Market Share
 
 4. Reusable (Cartridge) Insulin Pen Market Drivers and Barriers
 4.1 Market Drivers
 4.2 Market Barriers
 
 5. Reusable (Cartridge) Insulin Pen Market in Top Ten Countries – Geographical Landscape
 5.1 United States
 5.1.1 Overall Diabetes Population
 5.1.2 Insulin Users
 5.1.3 Reusable (Cartridge) Insulin Pen Users
 5.1.4 Reusable (Cartridge) Insulin Pen Market
 5.2 Germany
 5.2.1 Overall Diabetes Population
 5.2.2 Insulin Users
 5.2.3 Reusable (Cartridge) Insulin Pen Users
 5.2.4 Reusable (Cartridge) Insulin Pen Market
 5.3 France
 5.3.1 Overall Diabetes Population
 5.3.2 Insulin Users
 5.3.3 Reusable (Cartridge) Insulin Pen Users
 5.3.4 Reusable (Cartridge) Insulin Pen Market
 5.4 Italy
 5.4.1 Overall Diabetes Population
 5.4.2 Insulin Users
 5.4.3 Reusable (Cartridge) Insulin Pen Users
 5.4.4 Reusable (Cartridge) Insulin Pen Market
 5.5 Spain
 5.5.1 Overall Diabetes Population
 5.5.2 Insulin Users
 5.5.3 Reusable (Cartridge) Insulin Pen Users
 5.5.4 Reusable (Cartridge) Insulin Pen Market
 5.6 United Kingdom
 5.6.1 Overall Diabetes Population
 5.6.2 Insulin Users
 5.6.3 Reusable (Cartridge) Insulin Pen Users
 5.6.4 Reusable (Cartridge) Insulin Pen Market
 5.7 Japan
 5.7.1 Overall Diabetes Population
 5.7.2 Insulin Users
 5.7.3 Reusable (Cartridge) Insulin Pen Users
 5.7.4 Reusable (Cartridge) Insulin Pen Market
 5.8 China
 5.8.1 Overall Diabetes Population
 5.8.2 Insulin Users
 5.8.3 Reusable (Cartridge) Insulin Pen Users
 5.8.4 Reusable (Cartridge) Insulin Pen Market
 5.9 India
 5.9.1 Overall Diabetes Population
 5.9.2 Insulin Users
 5.9.3 Reusable (Cartridge) Insulin Pen Users
 5.9.4 Reusable (Cartridge) Insulin Pen Market
 5.10 Brazil
 5.10.1 Overall Diabetes Population
 5.10.2 Insulin Users
 5.10.3 Reusable (Cartridge) Insulin Pen Users
 5.10.4 Reusable (Cartridge) Insulin Pen Market
 
 6. Key Companies Analysis
 6.1 Novo Nordisk
 6.1.1 Business Overview
 6.1.2 Reusable Insulin Pen – Products Portfolio
 6.1.3 Insulin Pen – Latest Development & Trends
 6.2 Eli Lilly
 6.2.1 Business Overview
 6.2.2 Insulin Pen – Products Portfolio
 6.2.3 Insulin Pen – Latest Development & Trends
 6.3 Sanofi
 6.3.1 Business Overview
 6.3.2 Insulin Pen – Products Portfolio
 6.4 Owen Mumford
 6.4.1 Business Overview
 6.4.2 Insulin Pen – Products Portfolio
 6.5 Ypsomed
 6.5.1 Business Overview
 6.5.2 Insulin Pen – Products Portfolio
 6.5.3 Insulin Pen – Latest Development & Trends
 6.6 Biocon Ltd.
 6.6.1 Business Overview
 6.6.2 Insulin Pen – Products Portfolio


List Of Tables

 Table 3 1: 10 Countries – Reusable Insulin Pen Users Share (Percent), 2011 – 2016
 Table 3 2: 10 Countries – Forecast for Reusable Insulin Pen Users Share (Percent), 2017 – 2022
 Table 3 3: 10 Countries – Reusable Insulin Pen Market Share (Percent), 2011 – 2016
 Table 3 4: 10 Countries – Forecast for Reusable Insulin Pen Market Share (Percent), 2017 – 2022
 Table 4 2: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
  


List Of Figures

 

Figure 2 1: 10 Countries – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 2 2: 10 Countries – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 2 3: 10 Countries – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 2 4: 10 Countries – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 3: United States – Insulin Users(Thousand),2011 – 2016
Figure 5 4: United States – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 5: United States – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 6: United States – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 7: United States – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 8: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 9: Germany – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 10: Germany – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 11: Germany – Insulin Users(Thousand),2011 – 2016
Figure 5 12: Germany – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 13: Germany – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 14: Germany – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 15: Germany – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 16: Germany – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 17: France – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 18: France – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 19: France – Insulin Users(Thousand),2011 – 2016
Figure 5 20: France – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 21: France – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 22: France – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 23: France – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 24: France – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 25: Italy – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 26: Italy – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 27: Italy – Insulin Users(Thousand),2011 – 2016
Figure 5 28: Italy – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 29: Italy – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 30: Italy – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 31: Italy – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 32: Italy – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 33: Spain – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 34: Spain – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 35: Spain – Insulin Users(Thousand),2011 – 2016
Figure 5 36: Spain – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 37: Spain – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 38: Spain – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 39: Spain – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 40: Spain – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 41: United Kingdom – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 42: United Kingdom – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 43: United Kingdom – Insulin Users(Thousand),2011 – 2016
Figure 5 44: United Kingdom – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 45: United Kingdom – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 46: United Kingdom – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 47: United Kingdom – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 48: United Kingdom – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 49: Japan – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 50: Japan – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 51: Japan – Insulin Users(Thousand),2011 – 2016
Figure 5 52: Japan – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 53: Japan – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 54: Japan – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 55: Japan – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 56: Japan – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 57: China – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 58: China – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 59: China – Insulin Users(Thousand),2011 – 2016
Figure 5 60: China – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 61: China – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 62: China – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 63: China – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 64: China – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 65: India – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 66: India – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 67: India – Insulin Users(Thousand),2011 – 2016
Figure 5 68: India – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 69: India – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 70: India – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 71: India – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 72: India – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 73: Brazil – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 74: Brazil – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 75: Brazil – Insulin Users(Thousand),2011 – 2016
Figure 5 76: Brazil – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 77: Brazil – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 78: Brazil – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 79: Brazil – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 80: Brazil – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Companies Mentioned

Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.


Global Hematology Flow Cytometry Database

2024 Global Hematology and Flow Cytometry Database: US, Europe, Japan--Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts This database from provides the 2023 supplier shares, the 2023-2028

USD 14500 View Report

Global Hematology Market Shares Competitive Analysis

2023 Global Hematology Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides hematology market shares for France, Germany, Italy, Japan,

USD 1450 View Report

Global Diabetes Management Market Research Report

Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level. In the context of China-US trade war and COVID-19 epidemic, it will

USD View Report

Global Diabetes Care Analyzers Market Research Report 2023-2027

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Diabetes Care Analyzers Report by Material, Application, and Geography Global

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available